Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Gaze-Contingent Flicker Pupil Perimetry Detects Scotomas in Patients With Cerebral Visual Impairments or Glaucoma.

Naber M, Roelofzen C, Fracasso A, Bergsma DP, van Genderen M, Porro GL, Dumoulin SO.

Front Neurol. 2018 Jul 10;9:558. doi: 10.3389/fneur.2018.00558. eCollection 2018.

2.

Improvement in activities of daily living after visual training in patients with homonymous visual field defects using Goal Attainment Scaling.

Elshout JA, Bergsma DP, Sibbel J, Baars-Elsinga A, Lubbers P, Van Asten F, Visser-Meily J, Van Den Berg AV.

Restor Neurol Neurosci. 2018;36(1):1-12. doi: 10.3233/RNN-170719.

PMID:
29439358
3.

Segregation of Spontaneous and Training Induced Recovery from Visual Field Defects in Subacute Stroke Patients.

Bergsma DP, Elshout JA, van den Berg AV.

Front Neurol. 2017 Dec 15;8:681. doi: 10.3389/fneur.2017.00681. eCollection 2017.

4.

Radiotherapy for Oligometastatic Lung Cancer.

Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT.

Front Oncol. 2017 Sep 19;7:210. doi: 10.3389/fonc.2017.00210. eCollection 2017. Review.

5.

Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.

Cummings M, Youn P, Bergsma DP, Usuki KY, Walter K, Sharma M, Okunieff P, Schell MC, Milano MT.

Neurosurgery. 2018 Sep 1;83(3):437-444. doi: 10.1093/neuros/nyx427.

PMID:
28945885
6.

A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.

Chowdhry AK, Fung C, Chowdhry VK, Bergsma D, Dhakal S, Constine LS, Milano MT.

Leuk Lymphoma. 2018 May;59(5):1180-1187. doi: 10.1080/10428194.2017.1369063. Epub 2017 Sep 1.

PMID:
28862484
7.

Visual Rehabilitation in Chronic Cerebral Blindness: A Randomized Controlled Crossover Study.

Elshout JA, van Asten F, Hoyng CB, Bergsma DP, van den Berg AV.

Front Neurol. 2016 Jun 17;7:92. doi: 10.3389/fneur.2016.00092. eCollection 2016.

8.

Long-Term Survival of a Patient with Metastatic Small-Cell Carcinoma of the Stomach Treated with Radiation Therapy.

Bergsma DP, Schoeniger LO, Bratton L, Katz AW.

Case Rep Oncol. 2015 Oct 8;8(3):416-22. doi: 10.1159/000441021. eCollection 2015 Sep-Dec.

9.

The evolving role of radiotherapy in treatment of oligometastatic NSCLC.

Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT.

Expert Rev Anticancer Ther. 2015;15(12):1459-71. doi: 10.1586/14737140.2015.1105745. Epub 2015 Nov 4. Review.

PMID:
26536370
10.

Bladder cancer in the elderly patient: challenges and solutions.

Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C.

Clin Interv Aging. 2015 Jun 10;10:939-49. doi: 10.2147/CIA.S74322. eCollection 2015. Review.

11.

Lack of multisensory integration in hemianopia: no influence of visual stimuli on aurally guided saccades to the blind hemifield.

Ten Brink AF, Nijboer TC, Bergsma DP, Barton JJ, Van der Stigchel S.

PLoS One. 2015 Apr 2;10(4):e0122054. doi: 10.1371/journal.pone.0122054. eCollection 2015.

12.

Visual daily functioning of chronic stroke patients assessed by goal attainment scaling after visual restorative training: an explorative study.

Bergsma D, Baars-Elsinga A, Sibbel J, Lubbers P, Visser-Meily A.

Top Stroke Rehabil. 2014 Sep-Oct;21(5):400-12. doi: 10.1310/tsr2105-400.

PMID:
25341385
13.

The Role of Lung Lobes in Radiation Pneumonitis and Radiation-Induced Inflammation in the Lung: A Retrospective Study.

McCurdy M, Bergsma DP, Hyun E, Kim T, Choi E, Castillo R, Castillo E, Guerrero T.

J Radiat Oncol. 2013 Jun 1;2(2):203-208.

14.

Transfer effects of training-induced visual field recovery in patients with chronic stroke.

Bergsma DP, Elshout JA, van der Wildt GJ, van den Berg AV.

Top Stroke Rehabil. 2012 May-Jun;19(3):212-25. doi: 10.1310/tsr1903-212.

PMID:
22668676
15.

Spatial correspondence of 4D CT ventilation and SPECT pulmonary perfusion defects in patients with malignant airway stenosis.

Castillo R, Castillo E, McCurdy M, Gomez DR, Block AM, Bergsma D, Joy S, Guerrero T.

Phys Med Biol. 2012 Apr 7;57(7):1855-71. doi: 10.1088/0031-9155/57/7/1855. Epub 2012 Mar 13.

PMID:
22411124
16.

Measuring palinopsia: characteristics of a persevering visual sensation from cerebral pathology.

Van der Stigchel S, Nijboer TC, Bergsma DP, Barton JJ, Paffen CL.

J Neurol Sci. 2012 May 15;316(1-2):184-8. doi: 10.1016/j.jns.2012.01.006. Epub 2012 Jan 27.

17.

Oculomotor behavior of hemianopic chronic stroke patients in a driving simulator is modulated by vision training.

Bergsma DP, Leenders MJ, Verster JC, van der Wildt GJ, van den Berg AV.

Restor Neurol Neurosci. 2011;29(5):347-59. doi: 10.3233/RNN-2011-604.

PMID:
21811023
18.

Effects of vision restoration training on early visual cortex in patients with cerebral blindness investigated with functional magnetic resonance imaging.

Raemaekers M, Bergsma DP, van Wezel RJ, van der Wildt GJ, van den Berg AV.

J Neurophysiol. 2011 Feb;105(2):872-82. doi: 10.1152/jn.00308.2010. Epub 2010 Dec 15.

19.

Anomalous global effects induced by 'blind' distractors in visual hemifield defects.

Van der Stigchel S, Nijboer TC, Bergsma DP, Abegg M, Barton JJ.

Brain Cogn. 2010 Oct;74(1):66-73. doi: 10.1016/j.bandc.2010.06.006. Epub 2010 Jul 15.

PMID:
20637537
20.

Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma.

Bergsma D, Chen S, Buchweitz J, Gerszten R, Haab BB.

Mol Cell Proteomics. 2010 Mar;9(3):446-56. doi: 10.1074/mcp.M900418-MCP200. Epub 2009 Dec 18.

21.

Visual training of cerebral blindness patients gradually enlarges the visual field.

Bergsma DP, van der Wildt G.

Br J Ophthalmol. 2010 Jan;94(1):88-96. doi: 10.1136/bjo.2008.154336. Epub 2009 Aug 18.

PMID:
19692376
22.

Properties of the regained visual field after visual detection training of hemianopsia patients.

Bergsma DP, Van der Wildt GJ.

Restor Neurol Neurosci. 2008;26(4-5):365-75.

PMID:
18997312
23.

PEDF Promotes Biosynthesis of a Novel Anti-inflammatory and Anti-apoptotic Mediator NPD1 in Retinal Pigment Epithelial Cells.

Reinoso MA, Mukherjee P, Marcheselli V, Bergsma D, Hesse R, Bazan N.

Ochsner J. 2008 Spring;8(1):39-43.

24.

Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.

Chen S, LaRoche T, Hamelinck D, Bergsma D, Brenner D, Simeone D, Brand RE, Haab BB.

Nat Methods. 2007 May;4(5):437-44. Epub 2007 Apr 8.

PMID:
17417647
25.

Lions Clubs International Foundation Core Four Photoscreening: results from 17 programs and 400,000 preschool children.

Donahue SP, Baker JD, Scott WE, Rychwalski P, Neely DE, Tong P, Bergsma D, Lenahan D, Rush D, Heinlein K, Walkenbach R, Johnson TM.

J AAPOS. 2006 Feb;10(1):44-8.

PMID:
16527679
26.

AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1.

Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC.

J Biol Chem. 2001 Aug 3;276(31):28969-75. Epub 2001 May 31.

27.

Molecular cloning and functional characterization of MCH2, a novel human MCH receptor.

Hill J, Duckworth M, Murdock P, Rennie G, Sabido-David C, Ames RS, Szekeres P, Wilson S, Bergsma DJ, Gloger IS, Levy DS, Chambers JK, Muir AI.

J Biol Chem. 2001 Jun 8;276(23):20125-9. Epub 2001 Mar 27.

28.

Cloning, expression, and pharmacological characterization of a novel human histamine receptor.

Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, Herrity NC, Vawter L, Sarau HM, Ames RS, Davenport CM, Hieble JP, Wilson S, Bergsma DJ, Fitzgerald LR.

Mol Pharmacol. 2001 Mar;59(3):434-41.

PMID:
11179436
29.

A G protein-coupled receptor for UDP-glucose.

Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P, Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, Livi GP.

J Biol Chem. 2000 Apr 14;275(15):10767-71.

30.

Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry.

Wilson S, Bergsma D.

Drug Des Discov. 2000;17(2):105-14. Review. No abstract available.

PMID:
11045900
31.

Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid.

Fitzgerald LR, Dytko GM, Sarau HM, Mannan IJ, Ellis C, Lane PA, Tan KB, Murdock PR, Wilson S, Bergsma DJ, Ames RS, Foley JJ, Campbell DA, McMillan L, Evans N, Elshourbagy NA, Minehart H, Tsui P.

Biochem Biophys Res Commun. 2000 Jul 14;273(3):805-10.

PMID:
10891327
32.

Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor.

Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM.

J Biol Chem. 2000 Aug 25;275(34):25965-71.

33.

Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3.

Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu Hl, McMillan LJ, Guerrera S, Vawter L, Elshourbagy NA, Mooney JL, Bergsma DJ, Wilson S, Chambers JK.

J Biol Chem. 2000 Jul 7;275(27):20247-50.

34.

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA.

Nature. 1999 Sep 16;401(6750):282-6. Erratum in: Nature 1999 Dec 23-30;402(6764):898.

PMID:
10499587
35.

Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, Schmidt DB, Muccitelli RM, Jenkins O, Murdock PR, Herrity NC, Halsey W, Sathe G, Muir AI, Nuthulaganti P, Dytko GM, Buckley PT, Wilson S, Bergsma DJ, Hay DW.

Mol Pharmacol. 1999 Sep;56(3):657-63.

PMID:
10462554
36.

Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1.

Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, Sarau HM.

Nature. 1999 Jul 15;400(6741):261-5.

PMID:
10421367
37.

Orphan G-protein-coupled receptors: the next generation of drug targets?

Wilson S, Bergsma DJ, Chambers JK, Muir AI, Fantom KG, Ellis C, Murdock PR, Herrity NC, Stadel JM.

Br J Pharmacol. 1998 Dec;125(7):1387-92. Review.

38.

Molecular cloning and characterization of the porcine calcitonin gene-related peptide receptor.

Elshourbagy NA, Adamou JE, Swift AM, Disa J, Mao J, Ganguly S, Bergsma DJ, Aiyar N.

Endocrinology. 1998 Apr;139(4):1678-83.

PMID:
9528949
39.

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M.

Cell. 1998 Mar 6;92(5):1 page following 696. No abstract available.

40.

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M.

Cell. 1998 Feb 20;92(4):573-85.

41.

Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery.

Stadel JM, Wilson S, Bergsma DJ.

Trends Pharmacol Sci. 1997 Nov;18(11):430-7. Review.

PMID:
9426471
42.

Ser165 of transmembrane helix IV is not involved in the interaction of catecholamines with the alpha-2a-adrenoceptor.

Hehr A, Hieble JP, Li YO, Bergsma DJ, Swift AM, Ganguly S, Ruffolo RR Jr.

Pharmacology. 1997 Jul;55(1):18-24.

PMID:
9309797
43.

The Mizuo phenomenon in Oguchi disease.

Bergsma DR Jr, Chen CJ.

Arch Ophthalmol. 1997 Apr;115(4):560-1. No abstract available.

PMID:
9109775
44.

Visual field enlargement by neuropsychological training of a hemianopsia patient.

van der Wildt GJ, Bergsma DP.

Doc Ophthalmol. 1997;93(4):277-92.

PMID:
9665287
45.

Fine structure of the human galactokinase GALK1 gene.

Bergsma DJ, Ai Y, Skach WR, Nesburn K, Anoia E, Van Horn S, Stambolian D.

Genome Res. 1996 Oct;6(10):980-5.

46.

Molecular cloning and characterization of the human anaphylatoxin C3a receptor.

Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C, Zeng Z, Su K, Jurewicz AJ, Hertzberg RP, Bergsma DJ, Kumar C.

J Biol Chem. 1996 Aug 23;271(34):20231-4.

47.

A cDNA encoding the calcitonin gene-related peptide type 1 receptor.

Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y.

J Biol Chem. 1996 May 10;271(19):11325-9.

48.

Extensive detachment of Descemet membrane after holmium laser sclerostomy.

Bergsma DR Jr, McCaa CS.

Ophthalmology. 1996 Apr;103(4):678-80.

PMID:
8618771
49.

Mouse galactokinase: isolation, characterization, and location on chromosome 11.

Ai Y, Jenkins NA, Copeland NG, Gilbert DH, Bergsma DJ, Stambolian D.

Genome Res. 1995 Aug;5(1):53-9.

50.

Comparison of the enzymatic activities of human galactokinase GALK1 and a related human galactokinase protein GK2.

Ai Y, Basu M, Bergsma DJ, Stambolian D.

Biochem Biophys Res Commun. 1995 Jul 17;212(2):687-91.

PMID:
7542884

Supplemental Content

Loading ...
Support Center